Part 5: Recommending an Evidence-Based Practice Change Stephanie Nastasi Walden University, Study Guides, Projects, Research of Nursing

Download Part 5: Recommending an Evidence-Based Practice Change Stephanie Nastasi Walden University and more Study Guides, Projects, Research Nursing in PDF only on Docsity! Part 5: Recommending an Evidence-Based Practice Change Stephanie Nastasi Walden University NURS 6052: Essentials of Evidence-Based Practice October 25, 2019 Organizational Culture The organization I work in completely supports innovation and change. We are a professional Magnet facility that specializes in continuous organizational development with nurse involvement. My company encourages the workforce with ongoing education and training to bring about the desired change. To sustain health services, my organization acknowledges the need for groundbreaking learning in today's world. Knowledge Transfer ► The development of awareness should include a critical review of existing literature on the use of medical marijuana for chronic pain and anxiety vs. opioid therapy. ► Knowledge from several evidence-based approaches will be used to formulate an action strategy to be used by the institution. ► The information dissemination plan would include educating health care providers on the correct use of medical marijuana to support patients with chronic pain and anxiety. ► Staff training will also include workshops and educational seminars. ► Posters to make the public informed of the operation shall also be put in the strategic locations of the hospital. ► The implementation strategy for the company would include a policy change to incorporate the new methods. Measurable Outcomes ► Chronic pain and anxiety patients will experience improved symptom control under the aim will be used to assess the effect of the treatment. ► The goal will be to reduce pain and anxiety, as indicated by analog visual scales. ► The outcome will be a measurable difference in chronic pain and anxiety among participants from baseline to completion of the treatment. ► The secondary outcome is to reduce the dependency of opioids for the treatment of chronic pain and anxiety. Critical Appraisal Of The Peer- reviewed Articles Summary ► Feingold et al. (2017) used a randomized controlled trial design to assess and replace patients receiving opioid prescription medication with medical marijuana ► Report by Kosiba et al. (2019), a patient-reported meta-analysis review, using medical marijuana to find evidence for pain and anxiety relief. ► Dean et al. (2017) analysis examined medical marijuana's effectiveness in treating symptoms of pain, anxiety, and depression. ► Article Piper et al. (2017) provides sufficient data that patients have either cut back or discontinued their opioid prescription medicine due to the use of medical marijuana. Lessons Learned From Completing The Outcomes Synthesis Table ► It was a sufficient model design of the four peer-reviewed articles. ► The results and guidelines indicated that professional guidelines should endorse the use of medical marijuana as a treatment for chronic pain and anxiety. ► The overall quality of the four peer-reviewed articles was reliable and indicated the accuracy of the results. References Chronic Pain. (2016). Retrieved from https://adaa.org/understanding-anxiety/related-illnesses/other-related-conditions/chronic-pain. Dean, K. E., Ecker, A. H., & Buckner, J. D. (2017). Anxiety sensitivity and cannabis use-related problems: The impact of race. The American Journal on Addictions, 26(3), 209–214. doi: 10.1111/ajad.12511 Feingold, D., Brill, S., Goor-Aryeh, I., Delayahu, Y., & Lev-Ran, S. (2017). Depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuana. Journal of Affective Disorders, 218, 1–7. doi: 10.1016/j.jad.2017.04.026 Grinspoon, P. (2019). Medical marijuana. Retrieved from https://www.health.harvard.edu/blog/medical-marijuana-2018011513085. Kosiba, J. D., Maisto, S. A., & Ditre, J. W. (2019). Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta- analysis. Social Science & Medicine, 233, 181–192. doi: 10.1016/j.socscimed.2019.06.005 Piper, B. J., Dekeuster, R. M., Beals, M. L., Cobb, C. M., Burchman, C. A., Perkinson, L., … Abess, A. T. (2017). Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep. Journal of Psychopharmacology, 31(5), 569–575. doi: 10.1177/0269881117699616